CAPPELLO JOSEPH (VP, Pharmaceutical Development) sold 2.3% of their position (3.71K shares) of GENELUX CORP on the open market
Open‑market sale worth $14.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/11/2025ACC: 0001493152-25-027337
Officer· VP, Pharmaceutical Development
Since Jan 2023
-3.71K
Net shares
Net seller
$14.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
3.71K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−1.27K
Price / share
$3.33
Trade value
$4.22K
% of position
0.8%
8/21/2025
159.77K→158.50K
Common Stock
Direct
Shares
−1.46K
Price / share
$3.36
Trade value
$4.91K
% of position
0.9%
8/21/2025
158.50K→157.03K
Common Stock
Direct
Shares
−973.00
Price / share
$5.37
Trade value
$5.22K
% of position
0.6%
11/17/2025
157.03K→156.06K
Total
Net shares
−3.71K
Net value
-$14.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2025 | S · Sale | −1.27K | $3.33 | $4.22K | 0.8% | 159.77K | 158.50K |
| Common Stock Direct | 8/21/2025 | S · Sale | −1.46K | $3.36 | $4.91K | 0.9% | 158.50K | 157.03K |
| Common Stock Direct | 11/17/2025 | S · Sale | −973.00 | $5.37 | $5.22K | 0.6% | 157.03K | 156.06K |
| Total | −3.71K | -$14.36K | ||||||
Derivative Transactions0
No derivative transactions reported